Irene Robinson

Pharma

South Africa among the countries most heavily affected by COVID-19

Based on the current trajectory of COVID-19 daily confirmed cases, South Africa is among the most heavily affected countries in the world, with a forecast of 500,000 total confirmed cases in the next two weeks. Given that it is one of the most developed countries in Africa, its struggle to control the surge of new cases […]

Retail

Strong Kingfisher results show consumers yet to tire of home improvements

Following today’s release of Kingfisher Q2 figures to date for 2020/21, Amy Higginbotham, Retail Analyst at GlobalData, a leading data and analytics company, comments: ‘‘Kingfisher reports a strong performance for its Q2 to date (11 weeks to 18 July), boosted by ongoing elevated demand for home improvement as consumers stay home, and the phased reopening of stores […]

Pharma

Biogen can maintain dominance in SMA by demonstrating Spinraza benefits patients after Zolgensma treatment

Following the news that Biogen is planning a Phase IV trial to test Spinraza (nusinersen) in patients with spinal muscular atrophy (SMA) who have already been treated with Novartis’ gene therapy Zolgensma (onasemnogene abeparvovec); Philippa Salter, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “Biogen can maintain its dominance in […]

Oil & Gas

Chevron’s Noble Energy acquisition bets on future natural gas demand and more geographic diversity,

Following the news that Chevron is to acquire Noble Energy for $13bn; Adrian Lara, Senior Oil & Gas Analyst at GlobalData, a leading data and analytics company, offers his view: “Since the crash of oil price and demand in March 2020, there has been an increasing expectation for mergers and acquisition (M&A) activity to show […]

Retail

Online channel not enough to prop up Matalan through devastating COVID-19 lockdown

Following today’s release of Matalan Q1 figures for 2020/21, Sofie Willmott, Lead Retail Analyst at GlobalData, a leading data and analytics company, comments: ‘‘With Matalan’s stores only open for around five weeks of Q1, its underdeveloped online channel has not been strong enough to carry the value retailer through the COVID-19 crisis with total revenue almost […]

Travel & Tourism

Long haul travel preparations should be considered for eager UK millennials

UK millennials are the most likely to book an international trip in 2020 – with 49% agreeing* that they would rebook in a survey by GlobalData. Short haul travel trips to European destinations have now come into play, but the government need to collaborate with the aviation industry in order to start considering how long-haul flight operations will […]

Pharma

Tremfya’s approval could signal new era in PsA

Janssen, a subsidiary of Johnson and Johnson (J&J), recently announced that Tremfya (guselkumab) received Food and Drug Administration (FDA) approval for patients with active psoriatic arthritis (PsA). Despite being launched in a fairly mature market, if J&J is able to contract aggressively with pharmacy benefit managers, leading data and analytics company GlobalData expects that Tremfya […]

Medical Devices

Abbott Laboratories’ results show COVID-19 impact on certain medical device markets

Following the release of Abbott Laboratories Q2 2020 earnings results; Ashley Young, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “While Abbott reported an overall decrease in medical device sales in Q2 2020, the company also stated that procedures using its devices had begun to return to normal, pre-COVID-19 […]

Pharma

Moderna’s vaccine results are promising but more data is needed to assess length of protection

Following the promising results from Moderna’s mRNA vaccine Phase I trial; Johanna Swanson, Product Manager at GlobalData, a leading data and analytics company, offers her view: “The relative speed of production of mRNA vaccines is a clear advantage for Moderna, as mRNA vaccine manufacturing is relatively straightforward, compared with other vaccine types, and is an […]

Medical Devices

SyntheticMR’s SyMRI NEURO could boost MRI’s position in becoming COVID-19 diagnostic tool

Following the recent news that SyntheticMR will make SyMRI NEURO, its leading magnetic resonance imaging (MRI) solution, available for institutions that wish to scan COVID-19 patients prior to discharge; Dominic Tong, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view: “The US MRI market, worth $1.6bn in 2019 according to […]

Medical Devices

Smith & Nephew to be key player in robotics surgery market with hand-held robotic platform

Following the launch of Smith & Nephew’s new hand-held robotic platform for knee replacement surgery; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “GlobalData expects Smith & Nephew to be a key player in the robotics surgery market with the launch of its new unique robotics platform. […]

Pharma

Truvada likely to be preferred HIV prevention drug despite cabotegravir’s superiority

Following the results of a Phase IIb/III trial that showed GSK’s investigational HIV prevention drug cabotegravir had superior efficacy over Gilead’s Truvada; Arafa Salam, PhD, Infectious Diseases Analyst at GlobalData, a leading data and analytics, company offers her view: “Although cabotegravir may be more effective than Truvada, cabotegravir has potential high costs. Moreover, there are […]

Pharma

US’s new COVID-19 data system is concerning, but could be significant tool in fight against coronavirus

Following the recent news that the US Department of Health and Human Services (HHS) will be receiving data on COVID-19 hospitalizations from hospitals directly, bypassing the Centers for Disease Control and Prevention (CDC); Kasey Fu, Director of Epidemiology at GlobalData, a leading data and analytics company, offers her view on the potential implications of this […]

Pharma

Biogen’s aducanumab submission to the FDA could change Alzheimer’s disease landscape

Following Biogen’s submission of a Biologics License Application (BLA) to the FDA of aducanumab; Alessio Brunello, Managing Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “The potential approval for aducanumab is not likely to be the final treatment for Alzheimer’s disease (AD), but it could open doors for combination research, namely […]

Pharma

Hodgkin’s lymphoma market set to reach $2.1bn by 2029 driven by new combination therapies

The Hodgkin’s lymphoma (HL) market is expected to grow from $1.2bn in 2019 to $2.1bn in 2029 across the eight major markets (8MM*) at a moderate compound annual growth rate (CAGR) of 5.5%, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Hodgkin’s Lymphoma: Opportunity Analysis and Forecasts to 2029’, states […]

Medical Devices

COVID-19 continues to impact smaller companies as Endologix files for bankruptcy

Following Endologix’s announcement that it has filed for Chapter 11 bankruptcy protection and was purchased by its largest creditor Deerfield Partners who will take the company private; Sheryl Tang, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers her view: “The delay in elective procedures due to COVID-19 has resulted in financial […]

Oil & Gas

National oil companies in Latin America impacted by lack of partnerships due to COVID-19 pandemic

Latin America’s oil and gas sector is facing unprecedented challenges caused by a combined collapse in commodity prices and crude oil demand due to the COVID-19 pandemic. Most oil and gas companies in the region are state-owned therefore there are limited opportunities for these companies to establish successful partnerships with other operators. A sharing risk […]

Travel & Tourism

UK domestic tourism trips down by a FIFTH due to COVID-19 from 122 million in 2019 to 95 million in 2020

As the UK’s domestic tourism industry prepares to reopen on July 4, total UK domestic tourism trips are set to drop by 22% this year from 122.2 million in 2019 to 95 million in 2020, according to GlobalData, a leading data and analytics company. The UK travel and tourism industry has taken a real battering […]

Business Fundamentals

Global deal activity declined by 8% during week ended June 28

A total of 1,118 deals were announced globally during the week ended June 28, 2020, which is a decrease of 8% over 1,215 deals announced during the previous week, according to GlobalData’s deals database. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Global deal activity has remained inconsistent due to volatile market conditions since the COVID-19 […]

Pharma

67.3% of clinical trials disrupted by COVID-19 are due to enrollment suspension

Since early March, over a hundred companies have publicly announced disruptions to planned and ongoing clinical trials in their press releases, SEC filings, as well as on social media. Companies have delayed the initiation of planned trials or withdrawn these completely, as well as suspended enrolment in ongoing trials or terminated these trials. GlobalData, a […]

Prev 1 … 9 10 11 12 13 … 15 Next

South Africa among the countries most heavily affected by COVID-19

Strong Kingfisher results show consumers yet to tire of home improvements

Biogen can maintain dominance in SMA by demonstrating Spinraza benefits patients after Zolgensma treatment

Chevron’s Noble Energy acquisition bets on future natural gas demand and more geographic diversity,

Online channel not enough to prop up Matalan through devastating COVID-19 lockdown

Long haul travel preparations should be considered for eager UK millennials

Tremfya’s approval could signal new era in PsA

Abbott Laboratories’ results show COVID-19 impact on certain medical device markets

Moderna’s vaccine results are promising but more data is needed to assess length of protection

SyntheticMR’s SyMRI NEURO could boost MRI’s position in becoming COVID-19 diagnostic tool

Smith & Nephew to be key player in robotics surgery market with hand-held robotic platform

Truvada likely to be preferred HIV prevention drug despite cabotegravir’s superiority

US’s new COVID-19 data system is concerning, but could be significant tool in fight against coronavirus

Biogen’s aducanumab submission to the FDA could change Alzheimer’s disease landscape

Hodgkin’s lymphoma market set to reach $2.1bn by 2029 driven by new combination therapies

COVID-19 continues to impact smaller companies as Endologix files for bankruptcy

National oil companies in Latin America impacted by lack of partnerships due to COVID-19 pandemic

UK domestic tourism trips down by a FIFTH due to COVID-19 from 122 million in 2019 to 95 million in 2020

Global deal activity declined by 8% during week ended June 28

67.3% of clinical trials disrupted by COVID-19 are due to enrollment suspension

Browse

Company information